Patients with arthritis, n (%)Patients without arthritis, n (%)
No of subjects (n)58 (23.2%)192 (76.8%)
antiRo/antiLa antibodies36 (62.1%)80 (41.7%)
Rheumatoid Factor39 (67.2%)77 (39.6%)
Anti-citrullinated peptide antibodies (ACPA)7 (12.1%)2 (1.04%)
Presence of erosions3 (5.2%)0